Drug Type Small molecule drug |
Synonyms |
Target |
Action modulators |
Mechanism TAFA5 modulators(TAFA chemokine like family member 5 modulators) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhaseDiscovery |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Alzheimer Disease | Discovery | United States | 01 Jan 2025 | |
Sensation Disorders | Discovery | United States | 01 Jan 2025 |